- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03320837
Metabolomic Profile of Urine Samples From Neonates Fed With Breast Milk and an Infant Formula Enriched With Synbiotics (mtburnIFsynb)
Metabolomic Profile of Urine Samples From Neonates Fed Exclusively With Breast Milk as Compared With the Profile of Neonates Fed With an Infant Formula Enriched With Synbiotics
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Normal full-term infants aged 0-28 days, from singlet pregnancy, born by vaginal delivery or by caesarian section, with Apgar score >7 in the 1st and 5th minute, not requiring resuscitation during delivery, and with a normal intrauterine growth, i.e. between 11th and 89th percentile (AGA- appropriate for gestational age). The mother's medical history should be free of any chronic diseases and allergies, while the gestation history should be free of any complications and of any pharmaceutical treatment administration prior to delivery.
Exclusion criteria: insufficient weight gain and/or semiology of possible allergy to cow milk, hospitalization in NICU (Neonatal Intensive Care Unit), treatment of breastfeeding mother having given birth recently or of the neonate with antibiotics after delivery.
Method: 36 Infants in exclusive breastfeeding, 36 infants feeding exclusively on infant formula with synbiotics and 36 infants following mixed nutrition with breast milk and infant formula with synbiotics, for a period of 3 months have been selected on randomized basis. For all these three groups, the anthropometric parameters should be measured (length, weight, head perimeter), since the first day of newborn's inclusion in the trial and at the age of 15 days, 2 and 3 months. Moreover, at the age of 15 days, 2 months, 3 months and on the infant's inclusion day in the trial, newborns-infants urine sample should be collected by the attending doctor using a ball of cotton inserted into the disposable diaper and with the aid of an aspiration syringe the urine sample (2-3 ml) will be transferred to a sterile vial and finally stored at -80 °C. Then frozen urine samples will be sent in batches to a contracted diagnostic center in order to examine the metabolic profile of the three diets described above (exclusive breastfeeding, infant formula with synbiotics and mixed nutrition with breast milk and infant formula with synbiotics), with the help of NMR and selectively liquid chromatography /mass spectrometry (LC/MS). This urine collection gives reliable results and can be used in infants without causing any discomfort or side-effect.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Attiki
-
Athens, Attiki, Greece, 11528
- Aretaieio Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Normal full-term infants aged 0-28 days,
- From singlet pregnancy,
- Born by vaginal delivery or by caesarian section, with Apgar score >7 in the 1st and 5th minute,
- Not requiring resuscitation during delivery, and with a normal intrauterine growth, i.e. between 11th and 89th percentile (AGA- appropriate for gestational age).
Exclusion Criteria:
- Insufficient weight gain and/or semiology of possible allergy to cow milk,
- Hospitalization in NICU (Neonatal Intensive Care Unit),
- Treatment of breastfeeding mother having given birth recently or of the neonate with antibiotics after delivery.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Breastfeeding group
Infant are exclusively fed with breast milk
|
Breast milk
|
Mixed feeding group
Infants are fed with mixed nutrition with breast milk and Rontamil Complete 1®
|
Breast milk
Breast milk substitute containing synbiotics
|
Infant formula group
Infant are fed exclusively with Rontamil Complete 1®
|
Breast milk substitute containing synbiotics
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Metabolomic profile of urine samples
Time Frame: Newborn's age of 2 days
|
Then frozen urine samples will be sent in batches to a contracted diagnostic center in order to examine the metabolic profile of the three diets described above (exclusive breastfeeding, Rontamil Complete 1® and mixed nutrition with breast milk and Rontamil Complete 1®), with the help of NMR and selectively liquid chromatography /mass spectrometry (LC/MS).
This urine collection gives reliable results and can be used in infants without causing any discomfort or side-effect.
|
Newborn's age of 2 days
|
Metabolomic profile of urine samples
Time Frame: Newborn's age of 15 days
|
Then frozen urine samples will be sent in batches to a contracted diagnostic center in order to examine the metabolic profile of the three diets described above (exclusive breastfeeding, Rontamil Complete 1® and mixed nutrition with breast milk and Rontamil Complete 1®), with the help of NMR and selectively liquid chromatography /mass spectrometry (LC/MS).
This urine collection gives reliable results and can be used in infants without causing any discomfort or side-effect.
|
Newborn's age of 15 days
|
Metabolomic profile of urine samples
Time Frame: Newborn's age of 2 months
|
Then frozen urine samples will be sent in batches to a contracted diagnostic center in order to examine the metabolic profile of the three diets described above (exclusive breastfeeding, Rontamil Complete 1® and mixed nutrition with breast milk and Rontamil Complete 1®), with the help of NMR and selectively liquid chromatography /mass spectrometry (LC/MS).
This urine collection gives reliable results and can be used in infants without causing any discomfort or side-effect.
|
Newborn's age of 2 months
|
Metabolomic profile of urine samples
Time Frame: Newborn's age of 3 months
|
Then frozen urine samples will be sent in batches to a contracted diagnostic center in order to examine the metabolic profile of the three diets described above (exclusive breastfeeding, Rontamil Complete 1® and mixed nutrition with breast milk and Rontamil Complete 1®), with the help of NMR and selectively liquid chromatography /mass spectrometry (LC/MS).
This urine collection gives reliable results and can be used in infants without causing any discomfort or side-effect.
|
Newborn's age of 3 months
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Nicoletta Iacovidou, PhD, National and Kapodistrian University of Athens
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- metabolomicsurinesynbio3x36nmr
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infant Development
-
Société des Produits Nestlé (SPN)RecruitingInfant Development | Growth and Development | Infant Health | Infant Formula | Infant Nutritional Physiological PhenomenaSaudi Arabia
-
University of ArizonaMead Johnson NutritionRecruiting
-
Hugo W. Moser Research Institute at Kennedy Krieger...Johns Hopkins UniversityNot yet recruitingChild Development | Developmental Delay | Infant Development | Language Development
-
Children's Hospital Los AngelesBrigham and Women's Hospital, Boston USA; Wuqu' Kawoq - Maya Health Alliance...RecruitingInfant DevelopmentGuatemala
-
Northwestern UniversityStanford UniversityActive, not recruiting
-
University Hospital, MontpellierCompletedInfant DevelopmentFrance
-
Bellamy's Organic Pty LtdActive, not recruitingInfant DevelopmentChina
-
Columbia UniversityCompleted
-
Centre Hospitalier Intercommunal CreteilCompleted
-
University of WashingtonNational Institute of Neurological Disorders and Stroke (NINDS)TerminatedInfant DevelopmentUnited States
Clinical Trials on Breast milk
-
Ataturk UniversityMSc İlknur Budancamanak; Professor Kadir Şerafettin Tekgündüz; Associate Professor... and other collaboratorsCompleted
-
University of OxfordNational Institute for Health Research, United KingdomCompletedPremature Birth | Necrotizing Enterocolitis | Late-onset Invasive InfectionUnited Kingdom, Ireland
-
McMaster Children's HospitalUnknownNeurodevelopment | Postnatal Growth DisorderCanada
-
University of TurkuRecruiting
-
Laura KairThe Gerber Foundation; Children's Miracle NetworkCompletedExclusive Breastfeeding | Breastfeeding Duration | Donor Milk SupplementationUnited States
-
Bangabandhu Sheikh Mujib Medical University, Dhaka...UnknownPreterm Infant | IUGR
-
Assiut UniversityUnknownWeight Gain | Feeding Disorder Neonatal | Neonatal SEPSIS
-
Sibel KüçükoğluHealth Institutes of TurkeyCompletedNewborn; Vitality | Breastfeeding | Odors, BodyTurkey
-
Amphia HospitalCompletedPremature Infant | Breast Feeding, Exclusive | Puncture SkinNetherlands
-
Karolinska InstitutetActive, not recruitingDiabetes Mellitus, Type 2 | Diabetes Type 1 | GDMSweden